Table 2.
Distribution of scores of the anticholinergic burden scales in polypharmacy and non-polypharmacy population
| Scale | Polypharmacy Mean (range) |
No Polypharmacy Mean (range) |
|---|---|---|
| ACB score | 3.6 (0–10) | 2.21 (0–9) |
| ARS score | 1.4 (0–6) | 1.06 (0–6) |
| CRIDECO (CALS) | 3.4 (0–9) | 2.06 (0–9) |
| ADS score | 1.58 (0–6) | 1.17 (0–6) |
| AEC score | 1.55 (0–6) | 1.14 (0–8) |
| ALS score | 1.78 (0–7) | 1.04 (0–6) |
| CrAS score | 1.55 (0–7) | 0.95 (0–6) |
ACB Anticholinergic Cognitive Burden, ARS Anticholinergic Risk Scale, ADS Anticholinergic Drug Scale, ALS Anticholinergic Load Scale, CrAS Clinician-rated Anticholinergic Scale, AEC Anticholinergic Effect on Cognition, CALS CRIDECO Anticholinergic Load Scale, SD Standard Deviation